Agilent Technologies, Inc. (0HAV.L) LSE

126.82

-1.7912(-1.39%)

Updated at September 08 02:50PM

Currency In USD

Agilent Technologies, Inc.

Address

5301 Stevens Creek Boulevard

Santa Clara, CA 95051

United States of America

Phone

800 227 9770

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Employees

17900

First IPO Date

January 29, 2018

Key Executives

NameTitlePayYear Born
Mr. Padraig McDonnellChief Executive Officer, President & Director1.56M1972
Dr. Simon MaySVice President & President of LDG882,8551973
Mr. Henrick Ancher-JensenSenior Vice President and President of Order Fulfillment & Supply Chain990,7591965
Mr. Robert W. McMahon C.M.A.Senior Vice President & Chief Financial Officer1.17M1969
Mr. Parmeet AhujaVice President of Investor Relations0N/A
Mr. Frederick SchwarzSVice President, Chief Strategy & Corporate Development Officer0N/A
Ms. Meghan A. HensonSenior Vice President & Chief Human Resources Officer01970
Ms. Yvonne MackieMD of UK & Ireland Operations and Vice President of Human Resources - Europe0N/A
Mr. Rodney GonsalvesPrincipal Accounting Officer, Vice President & Corporate Controller01966
Mr. Bret M. DiMarcoSenior Vice President, Chief Legal Officer, & Secretary01968

Description

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.